Treatment with UA (50 mg/kg) dose-dependently restored oxidative balance, reducing MDA (~ 0.82-fold) and elevating SOD (~ 2.39-fold) and CAT (~ 2.11-fold) activities toward PCOS values (p ≤ 0.05). The gene discussed is SOD1; the disease is polycystic ovary syndrome.